What is the cost of the migraine drug Ajovy?

The list price* for Teva's Ajovy (fremanezumab-vfrm) is:

• $575 for the once-monthly dose
• $1,725 for the quarterly dose
• $6,900 over one year.

Ajovy, a preventive treatment of migraine in adults, is given as a 225 mg subcutaneous (under the skin) injection once every month or as a 675 mg subcutaneous injection once every 3 months (using three separate injections). Ajovy's list price is equivalent to the list prices for other approved calcitonin gene-related peptide (CGRP) migraine treatments, including Aimovig (erenumab-aooe) from Amgen, and Emgality (galcanezumab-gnlm) from Eli Lilly.

Most patients who are insured do not pay list price but pay a copay or co-insurance fee dependent upon how the drug is covered by their insurance. However, all three manufacturers do have programs in place to assist patients with financial costs, depending upon insurance coverage.